ERRE, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 4.189
AS - Asia 2.626
SA - Sud America 1.960
EU - Europa 1.274
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 10.171
Nazione #
US - Stati Uniti d'America 4.053
BR - Brasile 1.755
SG - Singapore 1.206
CN - Cina 626
UA - Ucraina 308
HK - Hong Kong 256
IT - Italia 226
DE - Germania 222
VN - Vietnam 135
FI - Finlandia 101
SE - Svezia 89
GB - Regno Unito 69
AR - Argentina 67
TR - Turchia 60
EC - Ecuador 54
CA - Canada 52
RU - Federazione Russa 52
MX - Messico 46
IN - India 44
IQ - Iraq 44
FR - Francia 41
BD - Bangladesh 38
ZA - Sudafrica 33
JP - Giappone 30
KR - Corea 30
PL - Polonia 30
AT - Austria 24
CO - Colombia 24
NL - Olanda 24
ID - Indonesia 19
UZ - Uzbekistan 19
BE - Belgio 18
MA - Marocco 18
PK - Pakistan 17
PY - Paraguay 16
ES - Italia 15
VE - Venezuela 15
TN - Tunisia 13
KE - Kenya 12
AZ - Azerbaigian 11
EG - Egitto 11
DO - Repubblica Dominicana 10
NP - Nepal 10
CL - Cile 9
CZ - Repubblica Ceca 9
PE - Perù 9
DZ - Algeria 8
LT - Lituania 8
PS - Palestinian Territory 8
SA - Arabia Saudita 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
JM - Giamaica 7
KZ - Kazakistan 7
AU - Australia 6
IE - Irlanda 6
IR - Iran 6
LB - Libano 6
PH - Filippine 6
GE - Georgia 5
HN - Honduras 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
JO - Giordania 4
OM - Oman 4
RO - Romania 4
SN - Senegal 4
CH - Svizzera 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
PA - Panama 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CV - Capo Verde 2
GR - Grecia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DJ - Gibuti 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
MD - Moldavia 1
Totale 10.157
Città #
Dallas 1.618
Singapore 654
Chandler 594
Hong Kong 247
Beijing 220
Ashburn 177
Jacksonville 151
Princeton 142
São Paulo 136
Sassari 73
New York 71
Shanghai 65
Los Angeles 64
Munich 61
Belo Horizonte 58
Helsinki 58
Wilmington 55
Dearborn 54
Ho Chi Minh City 50
Nanjing 48
Boardman 38
Rio de Janeiro 37
Santa Clara 35
Hanoi 31
Seoul 30
Tokyo 29
Brasília 28
Nanchang 28
Warsaw 26
Campinas 25
Ann Arbor 24
Columbus 24
Shenyang 23
The Dalles 23
Curitiba 22
Quito 22
Brooklyn 21
San Francisco 20
Stockholm 20
Toronto 20
Turku 20
Frankfurt am Main 19
London 19
Brussels 18
Johannesburg 18
Montreal 18
Mountain View 18
Porto Alegre 18
Chicago 17
Falkenstein 17
Istanbul 17
Piracicaba 17
Santo André 17
Atlanta 16
Denver 16
Guayaquil 16
Tashkent 16
Baghdad 15
Changsha 15
Chennai 15
Düsseldorf 15
Goiânia 15
Mexico City 15
Osasco 15
Ribeirão Preto 15
Fortaleza 14
Jiaxing 14
Phoenix 14
Ankara 13
Boston 13
Buenos Aires 13
Guangzhou 13
Salvador 13
Buffalo 12
Council Bluffs 12
Hebei 12
Juiz de Fora 12
Poplar 12
São José dos Campos 12
Vienna 12
Amsterdam 11
Baku 11
Betim 11
Campo Grande 11
Caxias do Sul 11
Dhaka 11
Hangzhou 11
Nairobi 11
Guarulhos 10
Izmir 10
Mogi das Cruzes 10
Mumbai 10
Natal 10
Romola 10
Taizhou 10
Tianjin 10
Aracaju 9
Belém 9
Jinan 9
João Pessoa 9
Totale 5.934
Nome #
A case of eruptive neurofibroma in a woman with neurofibromatosis during treatment with methotrexate 223
Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. 177
Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis 159
Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens 158
Association between lipoprotein levels and humoral reactivity to mycobacterium avium subsp. Paratuberculosis in multiple sclerosis, type 1 diabetes mellitus and rheumatoid arthritis 147
Significato clinico degli indici derivati dalle cellule figurate del sangue periferico come marcatori diagnostici dell’artrite reumatoide: studio caso – controllo. 144
Association Between Exposure to Heavy Metals and Systemic Sclerosis: the Levels of Al, Cd, Hg, and Pb in Blood and Urine of Patients 144
Asymmetric dimethylarginine: a key player in the pathophysiology of endothelial dysfunction, vascular inflammation and atherosclerosis in rheumatoid arthritis? 141
Scleroderma sera induce reactive oxygen species (ROS)-dependent activation of collagen synthesis in human pulmonary vascular smooth muscle cells 140
Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry 137
A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis 136
Diagnostic Accuracy of Anticarbamylated Protein Antibodies in Established Rheumatoid Arthritis: A Monocentric Cross-Sectional Study 135
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases 135
PtpA and PknG proteins secreted by mycobacterium avium subsp. Paratuberculosis are recognized by sera from patients with rheumatoid arthritis: A case– Control study 134
Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: A case–control study 130
Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis 130
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 129
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 126
Clinical utility of anti-lipoarabinomannan antibodies testing for the diagnosis of tuberculous arthritis. 123
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 122
Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis 119
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 117
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 117
Peripheral blood CD8+ T-cell profiles in patients with psoriatic arthritis: a cross-sectionale case-control study. 117
Reactive arthritis secondary to Hafnia alvei enterocolitis. 116
Oxidative Stress-Dependent Activation Of Collagen Synthesis Is Induced In Human Pulmonary Vascular Smooth Muscle Cells By Scleroderma Sera and Predicts Pulmonary Vascular Disease 113
Association between blood Pentraxin-3 concentrations and rheumatic diseases: A systematic review and meta-analysis 113
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography 111
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: A matter of dose and inflammation? 111
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology 110
Humoral response to microbial biomarkers in rheumatoid arthritis patients 110
Is there a role for imatinib mesylate in the treatment of eosinophilic granulomatosis with polyangiitis? 110
Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 108
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 108
Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study 108
Pachydermodactyly 107
Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis. 105
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 104
Association between ischemia-modified albumin (IMA) and peripheral endothelial dysfunction in rheumatoid arthritis patients 102
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 102
Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension 102
NADPH-derived ROS generation drives fibrosis and endothelial-to-mesenchymal transition in systemic sclerosis: Potential cross talk with circulating miRNAs 102
Visceral leishmaniasis among immunosuppressed patients with rheumatic diseases 101
Exposure of human pulmonary vascular smooth muscle cells to sera from patients with systemic sclerosis increases intracellular reactive oxygen species levels 97
Fibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation 96
Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study 96
Repurposing existing drugs for cardiovascular risk management: A focus on methotrexate 95
Role of infections in the pathogenesis of rheumatoid arthritis: Focus on mycobacteria 94
Diagnostic accuracy of different blood cells-derived indexes in rheumatoid arthritis A cross-sectional study 94
The sclerodermic hand: a radiological and clinical study 94
Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis 92
Decoding the Microbiome's Influence on Rheumatoid Arthritis 91
Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease 89
Mycobacterium tuberculosis lipoarabinomannan antibodies are associated to rheumatoid arthritis in Sardinian patients 89
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study 89
Genetics of Behçet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients. 87
Sera from Rheumatoid Arthritis Patients Induce Oxidative Stress and Pro-Angiogenic and Profibrotic Phenotypes in Human Endothelial Cells 85
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 85
Plasma L-Ergothioneina measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection 84
Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age 84
Methotrexate and Cardiovascular Protection: Current Evidence and Future Directions 83
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: Results from a multicentre cross-sectional study 82
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study 82
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 82
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis 81
Circulating Fetuin-A concentrations in rheumatic diseases: a systematic review and meta-analysis 80
Plasma L-ergothioneine measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection 80
Plasma Humanin and Non-Coding RNAs as Biomarkers of Endothelial Dysfunction in Rheumatoid Arthritis: A Pilot Study 78
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 78
Association of Rheumatoid Arthritis with Glucose-6-Phosphate Dehydrogenase Deficiency: Results from a Case-Control Study 77
Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications 76
Microbial players in autoimmunity: multicentric analysis of the association between Mycoplasma hominis serostatus and rheumatoid arthritis 76
Current therapeutic strategies in connective tissue disease-associated interstitial lung disease: introduction to the special issue 76
Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study 74
Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature 73
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 73
Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence 71
Subclinical hypothyroidism and cardiovascular risk factors 70
Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages 70
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 70
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 70
Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis? 69
Disease activity and disability influence CV risk estimation and management of rheumatoid arthritis patients 68
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 65
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients 64
VEGF in psoriatic arthritis: Systematic review and meta-analysis 64
Fibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation 64
Iloprost attenuates oxidative stress-dependent activation of collagen synthesis induced by sera from scleroderma patients in human pulmonary microvascular endothelial cells 63
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 63
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients 62
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study 62
Exploring endothelial dysfunction in major rheumatic diseases: current trends and future directions 60
Ultrasound in psoriatic arthritis. Can it facilitate a best routine practice in the diagnosis and management of psoriatic arthritis? 59
Immunomodulation for accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus 59
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 57
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 57
Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis 57
Diagnostic value of antifilaggrine antibodies (antibodies to cyclic citrullinated peptide and anti-keratin antibodies) for rheumatoid arthritis 56
Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: The AIRTRIP randomized clinical trial 55
Methotrexate and cardiovascular prevention: an appraisal of the current evidence 54
Totale 9.684
Categoria #
all - tutte 43.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 11 69 7 74 65 42 9
2021/2022355 31 0 1 1 3 7 7 27 34 42 56 146
2022/2023983 84 104 28 194 49 173 4 120 156 6 41 24
2023/2024373 47 25 9 9 63 29 5 51 1 6 47 81
2024/20253.706 32 25 177 126 129 149 252 750 1.181 569 183 133
2025/20263.801 260 1.241 772 813 636 79 0 0 0 0 0 0
Totale 10.348